Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Dayer

Showing results (231-240 of 260) with videos related to

Pageof 26
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 1, 1994
Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitisM Humbert, P Roux-Lombard, J Cerrina, et al.
The Journal of Rheumatology|December 22, 1999
Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritisF Spertini, A Leimgruber, B Morel, et al.
European Cytokine Network|June 5, 1998
Inflammation: "a natural experiment" for the systemic pathogenicity of cytokinesC Herbelin, P Roux-Lombard, A Herbelin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1995
Superantigen-induced collagenase gene expression in human IFN-gamma-treated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2K Mehindate, R al-Daccak, J M Dayer, et al.
Arthritis and Rheumatism|December 1, 1994
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein responseC Gabay, F Gay-Croisier, P Roux-Lombard, et al.
European Journal of Clinical Investigation|December 1, 1990
Cystic fibrosis patients' B-lymphocyte response is resistant to the in vitro enhancing effect of corticosteroidsD Emilie, M C Crevon, R Chicheportiche, et al.
Clinical and Experimental Rheumatology|March 31, 2009
Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritisF Oliviero, P Sfriso, G Baldo, et al.
Journal of Cellular Biochemistry|October 12, 2001
Phorbol diester 12-O-tetradecanoylphorbol 13-acetate (TPA) up-regulates the expression of estrogen receptors in human THP-1 leukemia cellsM Cutolo, G Carruba, B Villaggio, et al.
The Journal of Rheumatology|February 1, 1997
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activityC Gabay, N Cakir, F Moral, et al.
The Journal of Rheumatology|August 1, 1997
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluidA Desgeorges, C Gabay, P Silacci, et al.
Pageof 26

Showing results (231-240 of 260) with videos related to

Sort By:
Pageof 26
American Journal of Respiratory and Critical Care Medicine|June 1, 1994
Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitisM Humbert, P Roux-Lombard, J Cerrina, et al.
The Journal of Rheumatology|December 22, 1999
Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritisF Spertini, A Leimgruber, B Morel, et al.
European Cytokine Network|June 5, 1998
Inflammation: "a natural experiment" for the systemic pathogenicity of cytokinesC Herbelin, P Roux-Lombard, A Herbelin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1995
Superantigen-induced collagenase gene expression in human IFN-gamma-treated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2K Mehindate, R al-Daccak, J M Dayer, et al.
Arthritis and Rheumatism|December 1, 1994
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein responseC Gabay, F Gay-Croisier, P Roux-Lombard, et al.
European Journal of Clinical Investigation|December 1, 1990
Cystic fibrosis patients' B-lymphocyte response is resistant to the in vitro enhancing effect of corticosteroidsD Emilie, M C Crevon, R Chicheportiche, et al.
Clinical and Experimental Rheumatology|March 31, 2009
Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritisF Oliviero, P Sfriso, G Baldo, et al.
Journal of Cellular Biochemistry|October 12, 2001
Phorbol diester 12-O-tetradecanoylphorbol 13-acetate (TPA) up-regulates the expression of estrogen receptors in human THP-1 leukemia cellsM Cutolo, G Carruba, B Villaggio, et al.
The Journal of Rheumatology|February 1, 1997
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activityC Gabay, N Cakir, F Moral, et al.
The Journal of Rheumatology|August 1, 1997
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluidA Desgeorges, C Gabay, P Silacci, et al.
Pageof 26